Stay updated with breaking news from Regulatory Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Washington, DC (PRWEB) September 07, 2022 -- NDA Partners’ General Manager, Eric Fish, announced today that Dr. Daniela Drago, a senior global regulatory
Washington, DC (PRWEB) August 16, 2022 -- NDA Partners’ General Manager, Eric Fish, announced today thatBrian Tseng, MD, PhD, a board-certified pediatric
SOD1-ALS is a rare genetic form of ALS that affects approximately 330 people in the U.S.,1 it is progressive, leads to the loss of everyday functions and is uniformly fatalIf approved, tofersen would be
26.07.2022 - SOD1-ALS is a rare genetic form of ALS that affects approximately 330 people in the U.S.,1 it is progressive, leads to the loss of everyday functions and is uniformly fatalIf approved, tofersen would be the first treatment to target a genetic cause ... Seite 1
Cambridge, MA, Jan 28, 2022 - (JCN Newswire) - Biogen Inc. and Eisai Co., Ltd. (Tokyo, Japan) today announced additional details about the Phase 4 post-marketing confirmatory study, ENVISION, of ADUHELM